| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Mereo Biopharma Group PLC
13G/A
Amendment 2
MREO · 589492107
|
10.3% |
12/6/2024
Event 11/29/2024
|
|||
| Janus Henderson Group PLC | 10.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.3% | ||||
|
Applied Therapeutics, Inc.
13G/A
Amendment 2
APLT · 03828A101
|
10.4% |
12/6/2024
Event 11/29/2024
|
|||
| Janus Henderson Group PLC | 10.4% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.3% | ||||
|
Ardelyx Inc
13G/A
Amendment 4
ARDX · 039697107
|
10.1% |
12/6/2024
Event 11/29/2024
|
|||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.